| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |